The Valley Desk

NCT04640077 · Interventional trial

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

Overall registry status Completed

Phase 2

Conditions Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, Cognitive Impairment, Dementia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov